704-1120

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
704 (USA) · Dr. Tanaka
consented 2013-12-02

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild NASOPHARYNGITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-12-28 (study day 27.0); relationship: NONE

mild assessed

Mild NASOPHARYNGITIS — outcome: RECOVERED/RESOLVED; onset 2013-12-28 (study day 27.0); relationship: NONE

mild assessed

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-27 (study day 57.0); relationship: PROBABLE

moderate assessed

Moderate PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-27 (study day 57.0); relationship: PROBABLE

mild assessed

Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-12-23 (study day 22.0); relationship: PROBABLE

moderate assessed

Moderate RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-12-23 (study day 22.0); relationship: PROBABLE

Data queries

No data queries.